Findings of Research Misconduct, 7568-7569 [2011-2975]

Download as PDF 7568 Federal Register / Vol. 76, No. 28 / Thursday, February 10, 2011 / Notices necessary for the proper performance of the FDIC’s functions, including whether the information has practical utility; (b) the accuracy of the estimates of the burden of the information collection, including the validity of the methodology and assumptions used; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the information collection on respondents, including through the use of automated collection techniques or other forms of information technology. All comments will become a matter of public record. Dated at Washington, DC, this 4th day of February 2011. Federal Deposit Insurance Corporation. Robert E. Feldman, Executive Secretary. [FR Doc. 2011–2901 Filed 2–9–11; 8:45 am] BILLING CODE 6714–01–P FEDERAL MINE SAFETY AND HEALTH REVIEW COMMISSION Sunshine Act Meeting February 3, 2011. 10 a.m., Thursday, February 24, 2011. TIME AND DATE: The Richard V. Backley Hearing Room, 9th Floor, 601 New Jersey Avenue, NW., Washington, DC. PLACE: STATUS: Open. The Commission will consider and act upon the following in open session: Secretary of Labor v. North American Drillers, Inc., Docket Nos. LAKE 2008–2–R et al. (Issues include whether the judge erred in failing to grant the operator’s request for declaratory relief in a case where the Secretary had vacated the citation in question.) Any person attending this meeting who requires special accessibility features and/or auxiliary aids, such as sign language interpreters, must inform the Commission in advance of those needs. Subject to 29 CFR 2706.150(a)(3) and 2706.160(d). MATTERS TO BE CONSIDERED: Jean Ellen (202) 434–9950/(202) 708–9300 for TDD Relay/1–800–877–8339 for toll free. 10 a.m., Thursday, February 17, 2011. TIME AND DATE: The Richard V. Backley Hearing Room, 9th Floor, 601 New Jersey Avenue, NW., Washington, DC. PLACE: Emogene Johnson, Administrative Assistant. [FR Doc. 2011–3088 Filed 2–8–11; 4:15 pm] BILLING CODE 6735–01–P Open. MATTERS TO BE CONSIDERED: The Commission will hear oral argument in the matter Secretary of Labor v. North American Drillers, Inc., Docket Nos. LAKE 2008–2–R et al. (Issues include whether the judge erred in failing to grant the operator’s request for declaratory relief in a case where the Secretary had vacated the citation in question.) Any person attending this oral argument who requires special accessibility features and/or auxiliary aids, such as sign language interpreters, must inform the Commission in advance of those needs. Subject to 29 CFR 2706.150(a)(3) and 2706.160(d). Jean Ellen (202) 434–9950/(202) 708–9300 for TDD Relay/1–800–877–8339 for toll free. CONTACT PERSON FOR MORE INFO: jdjones on DSK8KYBLC1PROD with NOTICES Sunshine Act Meeting CONTACT PERSON FOR MORE INFO: February 3, 2011. STATUS: FEDERAL MINE SAFETY AND HEALTH REVIEW COMMISSION Emogene Johnson, Administrative Assistant. [FR Doc. 2011–3087 Filed 2–8–11; 4:15 pm] BILLING CODE 6735–01–P VerDate Mar<15>2010 15:10 Feb 09, 2011 Jkt 223001 FEDERAL RESERVE SYSTEM Change in Bank Control Notices; Acquisitions of Shares of a Bank or Bank Holding Company The notificants listed below have applied under the Change in Bank Control Act (12 U.S.C. 1817(j)) and § 225.41 of the Board’s Regulation Y (12 CFR 225.41) to acquire shares of a bank or bank holding company. The factors that are considered in acting on the notices are set forth in paragraph 7 of the Act (12 U.S.C. 1817(j)(7)). The notices are available for immediate inspection at the Federal Reserve Bank indicated. The notices also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing to the Reserve Bank indicated for that notice or to the offices of the Board of Governors. Comments must be received not later than February 25. 2011. PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 A. Federal Reserve Bank of Cleveland (Nadine Wallman, Vice President) 1455 East Sixth Street, Cleveland, Ohio 44101–2566 1. David E. Snyder; Sandra J. Snyder; Louella Snyder; Dennis C. Snyder; Kathy S. Snyder; Mark A. Snyder; Carolyn P. Snyder; Elizabeth K. Snyder; Benjamin T. Snyder; Michael D. Snyder; Sally A. Snyder; Charles R. Snyder Smith; Clayton R. Snyder Smith; Cameron R. Snyder Smith; Mark A. Karenchak; and Lisa M. Karenchak, all of Kittanning, Pennsylvania; Richard G. Snyder; Thomas C. Snyder; Debra L. Snyder; Andrew J. Snyder; and Meghan A. Snyder Kolbe, all of Cowansville, Pennsylvania; Roger H. Claypoole; Barbara L. Claypoole; Julie B.C. Doverspike; Brian H. Claypoole; and Angelique N. Claypoole, of Worthington, Pennsylvania; Alisha C. Snyder, Nevillewood, Pennsylvania; Gretchen L. Snyder, Templeton, Pennsylvania; Marsha L. Snyder, and Richard J. Krauland, both of Pittsburgh, Pennsylvania; Bryan K. Snyder; Sydney B. Snyder; Skylar A. Snyder; Brayden G. Snyder; and Alexis N. Snyder, all of Bradford, Pennsylvania; Kelly J. Holmberg, and Hailey J. Holmberg, both of Naples, Florida; and Charles H. Snyder, Jr., Ft. Myers, Florida; to acquire voting shares of Nextier, Inc., Butler, Pennsylvania, and thereby indirectly acquire voting shares of Nextier Bank N.A., Evans City, Pennsylvania. B. Federal Reserve Bank of Richmond (A. Linwood Gill, III, Vice President) 701 East Byrd Street, Richmond, Virginia 23261–4528 1. Richard T. Spurzem, individually, and Sandbox, LLC, both of Charlottesville, Virginia; to retain voting shares of Pioneer Bankshares, Inc., and thereby indirectly retain voting shares of Pioneer Bank, both of Stanley, Virginia. Board of Governors of the Federal Reserve System, February 7, 2011. Jennifer J. Johnson, Secretary of the Board. [FR Doc. 2011–2953 Filed 2–9–11; 8:45 am] BILLING CODE 6210–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary Findings of Research Misconduct Office of the Secretary, HHS. Notice. AGENCY: ACTION: Notice is hereby given that the Office of Research Integrity (ORI) SUMMARY: E:\FR\FM\10FEN1.SGM 10FEN1 Federal Register / Vol. 76, No. 28 / Thursday, February 10, 2011 / Notices jdjones on DSK8KYBLC1PROD with NOTICES has taken final action in the following case: Meleik Goodwill, Ph.D., Wadsworth Center, N.Y.S. Department of Health: Based on the Wadsworth Center report and the oversight review conducted by the Office of Research Integrity (ORI), the U.S. Public Health Service (PHS) found that Meleik Goodwill, Ph.D., former postdoctoral fellow, Wadsworth Center, N.Y.S. Department of Health, engaged in research misconduct in research supported by National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health (NIH), grant R21 ES013269–02. Specifically, PHS found that the Respondent engaged in research misconduct by the fabrication of data for growth curves presented in Figure 1 in the 2007 Journal of Neuroimmunology article (Goodwill, M.K., Lawrence, D.A., & Seegal, R.F. ‘‘Polychlorinated biphenyls induce proinflammatory cytokine release and dopaminergic dysfunction: Protection in interleukin-6 knockout mice.’’ Journal of Neuroimmunology 183(1–2):125–132, 2007), and by the use of composite images of Western-blot bands from unrelated experiments done in 2005 that were falsely labeled as if from different experiments to construct Figure 4A in the 2007 Journal of Neuroimmunology article. Figure 4B of the article also was falsified by use of identical sets of number for different treatments. The 2007 Journal of Neuroimmunology article was retracted in J. Neuroimmunol. 197(1):197, 2008. Dr. Goodwill has entered into a Voluntary Settlement Agreement in which she has voluntarily agreed, for a period of three (3) years, beginning on January 21, 2011: (1) That any institution that submits an application for PHS support for a research project on which the Respondent’s participation is proposed or that uses her in any capacity on PHS-supported research, or that submits a report of PHS-funded research in which she is involved, must concurrently submit a plan for supervision of her duties to ORI for approval; the supervisory plan must be designed to ensure the scientific integrity of her research contribution; Respondent agrees that she will not participate in any PHS-supported research until such a supervisory plan is submitted to ORI; (2) That any institution employing her submits, in conjunction with each application for PHS funds, or report, manuscript, or abstract involving PHSfunded research in which she was involved, a certification to ORI that the data provided are based on actual experiments or are otherwise legitimately derived and that the data, procedures, and methodology are accurately reported in the application or report; and VerDate Mar<15>2010 15:10 Feb 09, 2011 Jkt 223001 (3) To exclude herself voluntarily from service in any advisory capacity to PHS, including but not limited to service on any PHS advisory committee, board, and/or peer review committee, or as a consultant. FOR FURTHER INFORMATION CONTACT: Director, Division of Investigative Oversight, Office of Research Integrity, 1101 Wootton Parkway, Suite 750, Rockville, MD 20852, (240) 453–8800. John Dahlberg, Director, Division of Investigative Oversight, Office of Research Integrity. [FR Doc. 2011–2975 Filed 2–9–11; 8:45 am] BILLING CODE 4150–31–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Assistant Secretary for Planning and Evaluation; Medicare Program; Meeting of the Technical Advisory Panel on Medicare Trustee Reports Assistant Secretary for Planning and Evaluation, HHS. ACTION: Notice of meeting. AGENCY: This notice announces public meetings of the Technical Advisory Panel on Medicare Trustee Reports (Panel). Notice of these meetings is given under the Federal Advisory Committee Act (5 U.S.C. App. 2, section 10(a)(1) and (a)(2)). The Panel will discuss the long-term rate of change in health spending and may make recommendations to the Medicare Trustees on how the Trustees might more accurately estimate health spending in the long run. The Panel’s discussion is expected to be very technical in nature and will focus on the actuarial and economic assumptions and methods by which Trustees might more accurately measure health spending. Although panelists are not limited in the topics they may discuss, the Panel is not expected to discuss or recommend changes in current or future Medicare provider payment rates or coverage policy. Meeting Date: February 17, 2011, 9 a.m. to 6 p.m. e.t. ADDRESSES: The meetings will be held at HHS headquarters at 200 Independence Ave., SW., Washington, DC, 20201, Room TBA. Comments: The meeting will allocate time on the agenda to hear public comments. In lieu of oral comments, formal written comments may be submitted for the record to Donald T. Oellerich, OASPE, 200 Independence Ave., SW., 20201, Room 405F. Those submitting written comments should SUMMARY: PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 7569 identify themselves and any relevant organizational affiliations. FOR FURTHER INFORMATION CONTACT: Donald T Oellerich (202) 690–8410, Don.oellerich@hhs.gov. Note: Although the meeting is open to the public, procedures governing security procedures and the entrance to Federal buildings may change without notice. Those wishing to attend the meeting must call or e-mail Dr. Oellerich by Tuesday February 15, 2011, so that their name may be put on a list of expected attendees and forwarded to the security officers at HHS Headquarters. SUPPLEMENTARY INFORMATION: Topics of the Meeting: The Panel is specifically charged with discussing and possibly making recommendations to the Medicare Trustees on how the Trustees might more accurately estimate the long term rate of health spending in the United States. The discussion is expected to focus on highly technical aspects of estimation involving economics and actuarial science. Panelists are not restricted, however, in the topics that they choose to discuss. Procedure and Agenda: This meeting is open to the public. The Panel will likely hear presentations by HHS staff presentations regarding long range growth. After any presentations, the Panel will deliberate openly on the topic. Interested persons may observe the deliberations, but the Panel will not hear public comments during this time. The Panel will also allow an open public session for any attendee to address issues specific to the topic. Authority: 42 U.S.C. 217a; Section 222 of the Public Health Services Act, as amended. The panel is governed by provisions of Public Law 92–463, as amended (5 U.S.C. Appendix 2), which sets forth standards for the formation and use of advisory committees. Dated: February 3, 2011. Sherry Glied, Assistant Secretary for Planning and Evaluation. [FR Doc. 2011–3009 Filed 2–9–11; 8:45 am] BILLING CODE P DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Meeting of the Presidential Commission for the Study of Bioethical Issues The Presidential Commission for the Study of Bioethical Issues, Office of the Assistant Secretary for Health, Department of Health and Human Services. ACTION: Notice of Meeting. AGENCY: E:\FR\FM\10FEN1.SGM 10FEN1

Agencies

[Federal Register Volume 76, Number 28 (Thursday, February 10, 2011)]
[Notices]
[Pages 7568-7569]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-2975]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary


Findings of Research Misconduct

AGENCY: Office of the Secretary, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the Office of Research Integrity 
(ORI)

[[Page 7569]]

has taken final action in the following case:
    Meleik Goodwill, Ph.D., Wadsworth Center, N.Y.S. Department of 
Health: Based on the Wadsworth Center report and the oversight review 
conducted by the Office of Research Integrity (ORI), the U.S. Public 
Health Service (PHS) found that Meleik Goodwill, Ph.D., former 
postdoctoral fellow, Wadsworth Center, N.Y.S. Department of Health, 
engaged in research misconduct in research supported by National 
Institute of Environmental Health Sciences (NIEHS), National Institutes 
of Health (NIH), grant R21 ES013269-02.
    Specifically, PHS found that the Respondent engaged in research 
misconduct by the fabrication of data for growth curves presented in 
Figure 1 in the 2007 Journal of Neuroimmunology article (Goodwill, 
M.K., Lawrence, D.A., & Seegal, R.F. ``Polychlorinated biphenyls induce 
proinflammatory cytokine release and dopaminergic dysfunction: 
Protection in interleukin-6 knockout mice.'' Journal of Neuroimmunology 
183(1-2):125-132, 2007), and by the use of composite images of Western-
blot bands from unrelated experiments done in 2005 that were falsely 
labeled as if from different experiments to construct Figure 4A in the 
2007 Journal of Neuroimmunology article. Figure 4B of the article also 
was falsified by use of identical sets of number for different 
treatments. The 2007 Journal of Neuroimmunology article was retracted 
in J. Neuroimmunol. 197(1):197, 2008.
    Dr. Goodwill has entered into a Voluntary Settlement Agreement in 
which she has voluntarily agreed, for a period of three (3) years, 
beginning on January 21, 2011:

    (1) That any institution that submits an application for PHS 
support for a research project on which the Respondent's 
participation is proposed or that uses her in any capacity on PHS-
supported research, or that submits a report of PHS-funded research 
in which she is involved, must concurrently submit a plan for 
supervision of her duties to ORI for approval; the supervisory plan 
must be designed to ensure the scientific integrity of her research 
contribution; Respondent agrees that she will not participate in any 
PHS-supported research until such a supervisory plan is submitted to 
ORI;
    (2) That any institution employing her submits, in conjunction 
with each application for PHS funds, or report, manuscript, or 
abstract involving PHS-funded research in which she was involved, a 
certification to ORI that the data provided are based on actual 
experiments or are otherwise legitimately derived and that the data, 
procedures, and methodology are accurately reported in the 
application or report; and
    (3) To exclude herself voluntarily from service in any advisory 
capacity to PHS, including but not limited to service on any PHS 
advisory committee, board, and/or peer review committee, or as a 
consultant.

FOR FURTHER INFORMATION CONTACT: Director, Division of Investigative 
Oversight, Office of Research Integrity, 1101 Wootton Parkway, Suite 
750, Rockville, MD 20852, (240) 453-8800.

John Dahlberg,
Director, Division of Investigative Oversight, Office of Research 
Integrity.
[FR Doc. 2011-2975 Filed 2-9-11; 8:45 am]
BILLING CODE 4150-31-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.